Eye News and Research

Latest Eye News and Research

Report: Quality of care for insured Americans slipped in 2008

CNNMoney reports that for the first time in more than 10 years, the "overall quality of health care" for Americans insured through commercial and public plans appears to have slipped.

23 Oct 2009

Ellex Medical Lasers to launch latest version of Eye Cubed diagnostic ultrasound system

Ellex Medical Lasers Limited, a global leader in the design and manufacture of ophthalmic laser and ultrasound systems, today announced that it will introduce the latest version of the Eye Cubed(TM) diagnostic ultrasound system at the annual meeting of the American Academy of Ophthalmology (AAO), October 24 - 27, 2009 in San Francisco.

23 Oct 2009

Positive results from Aerie Pharmaceuticals’ Phase 2a study of its Rho-kinase inhibitor

Aerie Pharmaceuticals, a biotechnology company focused on the discovery and development of novel treatments for glaucoma, today announced positive results from a Phase 2a study of its Rho-kinase (ROCK) inhibitor, AR-12286. The study evaluated the safety, tolerability and efficacy of three different doses of AR-12286 in 88 patients with primary open angle glaucoma or ocular hypertension.

22 Oct 2009

Mead Johnson announces its financial results for the third quarter ended Sept. 30, 2009

Mead Johnson Nutrition Company announced today its financial results for the third quarter ended Sept. 30, 2009.

22 Oct 2009

Cosmetic procedures for a competitive edge in the workplace

As the unemployment numbers heat up, so does the competition for available jobs. To get an edge, increasing numbers of job seekers are looking to cosmetic procedures to give them confidence and a competitive edge in the workplace. Indeed, a recent survey released by The American Society of Plastic Surgeons (ASPS) supports this.

22 Oct 2009

ISTA Pharmaceuticals' presentations on Phase 3 clinical results of Bepreve

ISTA Pharmaceuticals, Inc. today announced poster presentations of results from the Company's Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5% Phase 3 clinical studies in allergic conjunctivitis. The studies demonstrated Bepreve was safe and well-tolerated when given twice daily for six weeks in a healthy pediatric population as young as three years of age.

22 Oct 2009

GeckoSystems to discuss its sensor fusion based vision system

GeckoSystems Intl. Corp. (http://www.geckosystems.com/) -- announced today that during their first annual "Mobile Robots in Motion" conference November 4-5, 2009 attendees will be able to observe and discuss GeckoSystems' sensor fusion based vision system, the CompoundSensorArray™.

22 Oct 2009

VisionGraft Sterile Cornea allograft now available at Tissue Banks International

Tissue Banks International (TBI) has announced the availability of the VisionGraft Sterile Cornea, the nation's first sterile cornea allograft. The VisionGraft Sterile Cornea (patent pending) is an irradiated cornea for use in tectonic transplant procedures.

22 Oct 2009

Electronic eye implant mimics human retina; restores partial vision

A 50-year-old New York woman who was diagnosed with a progressive blinding disease at age 13 was implanted with an experimental electronic eye implant that has partially restored her vision. A team led by Dr. Lucian V. Del Priore at NewYork-Presbyterian Hospital/Columbia University Medical Center performed the June 26 surgery -- the first case of its kind in New York.

22 Oct 2009

White House offer on malpractice finds takers; Obama tells Dems to 'focus'

Since President Obama proposed using $25 million to test new ways to handle malpractice lawsuits, suitors have been lining up, the The Asssociated Press reports. One leading idea is to appoint expert panels to sort fact from fiction in malpractice claims.

22 Oct 2009

VisionCare Ophthalmic Technologies to present on its implantable telescope technology

VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices for individuals with age-related macular degeneration (AMD), today announced upcoming scientific and corporate presentations on its implantable telescope technology.

21 Oct 2009

Certain molecules found to play an important role in regulating circadian rhythm: Study

Molecules that may hold the key to new ways to fight cancer and other diseases have been found to play an important role in regulating circadian rhythm, says Liheng Shi, a researcher in Texas A&M's Department of Veterinary Integrative Biosciences.

21 Oct 2009

Lux Biosciences to present on LX211 at 2009 AAO annual conference

Lux Biosciences, Inc., a privately held biotechnology company focused on the development and commercialization of therapies for serious ophthalmic diseases, today announced that the company’s experimental drug LX211 (LUVENIQ; oral voclosporin) will be featured in several presentations at the 2009 American Academy of Ophthalmology annual conference and American Uveitis Society meeting being held October 24-26 in San Francisco.

21 Oct 2009

Auxano point-of-care indicator system for dry eye syndrome

Auxano Diagnostics, LLC, a subsidiary of Auxano Biomedical, LLC, has announced the application of the company’s breakthrough wound care technology to the treatment of dry eye syndrome (DES) with the Auxano point-of-care indicator system.

21 Oct 2009

FDA grants Fast Track designation for MacuSight's Perceiva

MacuSight, a developer of innovative therapeutics for the treatment of severe ocular diseases and conditions, today announced that it has received Fast Track designation from the United States Food and Drug Administration (FDA) for Perceiva, the company's proprietary ocular sirolimus product, for the treatment of diabetic macular edema (DME).

21 Oct 2009

Gamida Cell and Cellerixon collaborate to develop new line of cell therapeutics

Gamida Cell Ltd. and Cellerix, S.A. announced today that the companies are collaborating on a feasibility study to evaluate the added value of combining the proprietary technologies of each.

21 Oct 2009

First Edition: October 21, 2009

As Senate Democrats wrestle with a doctor payment bill separate from sweeping health care reform proposals, the public plan, public opinion and health care costs continue to be a Capitol Hill focus.

21 Oct 2009

Organic, zero calorie carbonated soft drink from Steaz

Steaz, the nation's premier brand of organic and fair-trade beverages, introduces Steaz Zero Calorie Sparkling Green Tea -- the first certified organic, all-natural zero calorie carbonated soft drink.

21 Oct 2009

New website provides advice on health care and lifestyle options

When Regence member Adrianne Johnson needed to find a primary care physician (PCP), she asked friends for recommendations, and then logged on to myRegence.com to compare those recommendations with feedback from other Regence members who were patients of those doctors. Based on the Member Reviews she read on myRegence.com, Johnson was able to find not just a PCP she was comfortable with, but specialists, as well.

21 Oct 2009

Abbott acquires Visiogen; expands vision care business

Abbott today announced that it has completed its acquisition of privately held eye care company Visiogen, expanding the company's vision care business with a next-generation accommodating intraocular lens (IOL) technology to address presbyopia for cataract patients.

21 Oct 2009